Embolization Agents Market Latest Trends and Future Growth Study by 2025


Embolization agents are used to acutely stop the flow in a blood vessel or vascular territory by the means of mechanical occlusion. Embolization is a common procedure in interventional radiology. Traumatic injuries is the first common application of embolization techniques. Numerous embolic agents are available, each one with different properties and uses. The selection of agent depends on the clinical application; for example, trauma, vascular malformations, male infertility, tumors, and impotence. Embolization agents are classified into temporary agents and permanent agents depending on the period of time for which vascular occlusion is required.

Factors such as new product approval, growing prevalence of chronic diseases (such as cancer and vascular diseases), unmet needs, increasing health care expenditure, and rising number of road accidents leading to trauma would drive the Embolization Agents Market in the next few years. The global health care industry expanded by 6.9% to reach US$ 1.68 Trn in 2016, with the industry in Asia Pacific registering a double-digit growth rate. Increasing number of clinical trials, rising number of pipeline products, and technological advancements are other factors augmenting the embolization agents market.

Request to View Brochure of Report –


Rapid evolution of the microcatheter technology has led to development of numerous embolic agents that are compatible with microcatheters. A growing number of embolic agents are designed specifically for use with the microcatheter technology. On the other hand, unfavorable reimbursement scenario and stringent government regulations are key factors that may hamper the global embolization agents market during the forecast period.

Also Read:  Global Music Market Research by Key players, Type and Application, Future Growth to 2025

The embolization agents market has been segmented based on product, application, end-user, and geography. In terms of product, the market has been classified into permanent large-vessel occluders, permanent small-vessel occluders, temporary large-vessel occluders, and temporary small-vessel occluders. The permanent large-vessel occluders segment has been sub-classified into coils, balloons, amplatz vascular plugs, guidewires, silk suture material, porcine submucosa, and amplatz vascular obstruction devices. The permanent small-vessel occluders segment has been sub-divided into liquid sclerosants, liquid adhesives, ethiodol, thrombin, and ethylene–vinyl alcohol copolymer. The temporary large-vessel occluders segment has been sub-classified into gel foam sponges and autologous clots. The temporary small-vessel occlusions segment has been sub-divided into gel foam powder starch microspheres and fibrillated collagen. In terms of application, the embolization agents market has been classified into trauma, chemoembolization, tumors, and vascular malformations. In terms of end-user, the market has been segmented into hospitals, clinics, radiology centers, and ambulatory surgery centers.

Request to View ToC of Report –


Geographically, the global embolization agents market has been classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global embolization agents market due to advanced health care infrastructure, high health care spending, and presence of a large number of cancer patients in the region. According to Cancer Statistics 2016, pancreatic cancer is expected to exceed breast cancer to become the third leading cause of cancer-related deaths in the U.S. Factors such as growing geriatric population and increasing number of surgical procedures make Europe the second-largest market for embolization agents. According to the Lancet Commission on Global Surgery, about 15,000 surgical procedures per 100,000 people are performed in the U.K. every year. The market in the Asia Pacific region is expected to expand at a higher rate during the forecast period, due to rising health care expenditure, favorable government initiatives, boom in the economy, developing health care infrastructure, rising prevalence of chronic diseases, growing awareness among people, and increasing R&D activities in the region. In Southeast Asia, the private health care expenditure is higher compared to the government expenditure.

Also Read:  Global Marine Energy Market Business Opportunities Including Key Players Forecast Till 2025

Major players operating in the global embolization agents market are Boston Scientific Corporation, Stryker Corporation, Penumbra, Inc., Terumo Corporation, Medtronic Public Limited, Pfizer Inc., St. Jude Medical, LLC, and Cook Medical.

Enquiry for discount on this report –


About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.


US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com


Go to website